﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>24</Volume>
      <Issue>9</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2021</Year>
        <Month>09</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Relapse of Lymphangioleiomyomatosis Five Years after Bilateral-Lung Transplantation</ArticleTitle>
    <FirstPage>701</FirstPage>
    <LastPage>703</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.2021.101</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jalal</FirstName>
        <LastName>Heshmatnia</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2966-4380</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam Sadat</FirstName>
        <LastName>Mirenayat</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0852-1666</Identifier>
      </Author>
      <Author>
        <FirstName>Mitrasadat</FirstName>
        <LastName>Rezaei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7242-5839</Identifier>
      </Author>
      <Author>
        <FirstName>Felix</FirstName>
        <LastName>Bongomin</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4515-8517</Identifier>
      </Author>
      <Author>
        <FirstName>Mehrdad</FirstName>
        <LastName>Bakhshayeshkaram</LastName>
      </Author>
      <Author>
        <FirstName>Payam</FirstName>
        <LastName>Tabarsi</LastName>
      </Author>
      <Author>
        <FirstName>Kambiz</FirstName>
        <LastName>Sheikhy</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3565-9801</Identifier>
      </Author>
      <Author>
        <FirstName>Vida</FirstName>
        <LastName>Mortezaee</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0623-2307</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.2021.101</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <Abstract>Pulmonary lymphangioleiomyomatosis (LAM) is an uncommon disease principally affecting women during childbearing years and eventually leading to progressive respiratory failure. Lung transplantation is a viable option for patients with end-stage disease. LAM-related complications remain common, but recurrence of LAM following allograft transplantation is rare. We present a 25-year-old woman who presented with progressive dyspnea five years after bilateral lung transplantation for end-stage LAM. Histological examination of transbronchial lung biopsy sample confirmed recurrent LAM. We changed cyclosporine to sirolimus and she is currently being considered for re-transplantation. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Lung</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Lymphangioleiomyomatosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Transplantation</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>